fbpx
Our Research > Past Research Projects

Our Research
Success

Since established we have funded over 30 different research project. Some have led to breakthroughs including the development of novel treatments currently in pre-clinical trials

Past Research

studying the problem of relapses within the central nervous system (CNS) in children with acute lymphoblastic leukaemia (ALL)

ALL is the commonest cancer of childhood and treatment related toxicity and relapse are important therapeutic challenges. To further improve outcome new, non-toxic, targeted therapies need to be developed. These may be targeted to the…

Find Out More

Self-esteem and children with CNS tumours

The personal response of children to treatment for cancer is important for their well being during treatment and can impact on outcomes such as health-related quality of life, health status and psychological well being afterwards….

Find Out More

Developing Vascular Targeting Agents as a Method Combating Childhood cancers

This project is focused on the understanding and development of a new class of cancer drug targeting proteins involved in angiogenesis. These agents do not directly kill tumour cells – instead they destroy the blood…

Find Out More

Design and synthesis of new anticancer agents for the treatment of Leukaemia

Aromatic planar compounds are known to interact with DNA and some of the most widely used anticancer agents belong to this family known as intercalators. The project will synthesis a new family of agents and…

Find Out More

Studies towards the asymmetric synthesis of novel antimitotic agents

A number of compounds are known which bind to the colchicine binding site on tubulin, preventing the assembly of microtubules and thus preventing cancer cells from dividing. The project will establish methodologies for the synthesis…

Find Out More

Effects of a new class of leukaemia drug on normal myeloid leukocytes and lymphocytes

Assessing the effects of a new class of leukaemia drug on normal myeloid leukocytes and lymphocytes this includes neutrophils, monocytes, eosinophils, basophils, T-cells, B-cells and natural killer cells. The project will produce valuable data regarding…

Find Out More

NEIL3 as a new target for cancer therapy

NEIL3 is a DNA glycosylase that has activity in vitro by releasing oxidised bases from DNA. Of interest to the field of cancer research, NEIL3 has been found to be highly expressed in cancer cell…

Find Out More

Newsletter Sign Up